Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Rebecca Strawbridge, PhD
Articles
Multimodal Markers and Biomarkers of Treatment
July 31st 2018The use of biomarkers to assist with optimizing treatment decisions for depression has been receiving increasing attention. Here is an overview of the challenges and barriers that must be overcome before therapeutic markers can effectively be utilized in practice.
Latest Updated Articles
Published: July 12th 2025 | Updated: July 14th 2025
Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia
Published: July 12th 2025 | Updated: July 14th 2025
Treatment-Resistant Depression and Well-Rounded Care, With Alejandro Alva at Southern California Psychiatry
Published: March 11th 2020 | Updated: July 14th 2025
Mini Quiz: Coronavirus Outbreak and Mental Illness
Published: July 12th 2025 | Updated: July 14th 2025
Well-Rounded Examination for Treatment of Tardive Dyskinesia
Published: July 12th 2025 | Updated: July 14th 2025
Awareness of Multiple Treatment Options for Tardive Dyskinesia: Tips from Dr Jonathan Meyer
Published: July 13th 2025 | Updated: July 14th 2025
Robust Efficacy and Decreased Side Effects with New Muscarinic Agent for Treating Schizophrenia
